Globus Medical Inc (GMED)
84.72
-0.19
(-0.22%)
USD |
NYSE |
Nov 22, 16:00
84.72
0.00 (0.00%)
Pre-Market: 20:00
Globus Medical Cash from Operations (Quarterly): 203.65M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 203.65M |
| June 30, 2024 | 54.26M |
| March 31, 2024 | 52.39M |
| December 31, 2023 | 104.67M |
| September 30, 2023 | 50.48M |
| June 30, 2023 | 35.03M |
| March 31, 2023 | 53.31M |
| December 31, 2022 | 63.98M |
| September 30, 2022 | 32.92M |
| June 30, 2022 | 36.88M |
| March 31, 2022 | 44.69M |
| December 31, 2021 | 76.25M |
| September 30, 2021 | 77.26M |
| June 30, 2021 | 59.19M |
| March 31, 2021 | 63.57M |
| December 31, 2020 | 80.18M |
| September 30, 2020 | 53.25M |
| June 30, 2020 | 23.07M |
| March 31, 2020 | 42.29M |
| December 31, 2019 | 54.31M |
| September 30, 2019 | 55.87M |
| June 30, 2019 | 22.60M |
| March 31, 2019 | 39.20M |
| December 31, 2018 | 44.29M |
| September 30, 2018 | 51.79M |
| Date | Value |
|---|---|
| June 30, 2018 | 33.27M |
| March 31, 2018 | 52.30M |
| December 31, 2017 | 44.84M |
| September 30, 2017 | 34.80M |
| June 30, 2017 | 25.98M |
| March 31, 2017 | 53.45M |
| December 31, 2016 | 26.34M |
| September 30, 2016 | 42.65M |
| June 30, 2016 | 23.27M |
| March 31, 2016 | 55.56M |
| December 31, 2015 | 46.13M |
| September 30, 2015 | 30.05M |
| June 30, 2015 | 13.16M |
| March 31, 2015 | 34.67M |
| December 31, 2014 | 1.945M |
| September 30, 2014 | 35.64M |
| June 30, 2014 | 12.35M |
| March 31, 2014 | 29.23M |
| December 31, 2013 | 32.66M |
| September 30, 2013 | 33.56M |
| June 30, 2013 | 8.98M |
| March 31, 2013 | 18.28M |
| December 31, 2012 | 24.74M |
| September 30, 2012 | 16.90M |
| June 30, 2012 | 12.03M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
23.07M
Minimum
Jun 2020
203.65M
Maximum
Sep 2024
63.08M
Average
53.79M
Median
Cash from Operations (Quarterly) Benchmarks
| Boston Scientific Corp | 1.002B |
| Haemonetics Corp | 48.82M |
| ResMed Inc | 325.54M |
| AngioDynamics Inc | -18.25M |
| Stryker Corp | 1.474B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -14.97M |
| Cash from Financing (Quarterly) | 19.58M |
| Free Cash Flow | 293.77M |
| Free Cash Flow Per Share (Quarterly) | 1.171 |
| Free Cash Flow to Equity (Quarterly) | 155.04M |
| Free Cash Flow to Firm (Quarterly) | 162.41M |
| Free Cash Flow Yield | 2.53% |